Glucagon-Like Peptide-1 (GLP-1) Analog Liraglutide Inhibits Endothelial Cell Inflammation through a Calcium and AMPK Dependent Mechanism-Reference-Cited by-同舟云学术

Glucagon-Like Peptide-1 (GLP-1) Analog Liraglutide Inhibits Endothelial Cell Inflammation through a Calcium and AMPK Dependent Mechanism

Published:2014-05-16 Issue:5 Volume:9 Page:e97554
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Krasner Nadia M.,Ido Yasuo,Ruderman Neil B.,Cacicedo Jose M.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference58 articles.

1. Glucagon- like peptide 1 stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line;D Drucker;Proc Natl Acad Sci USA,1987

2. Glucagon-like peptide-1 7–36: A physiological incretin in man;B Kreymann;Lancet,1987

3. Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogue;D Russell-Jones;Mol Cell Endocrinol,2009

4. No impairment of hypoglycemia counterregulation via glucagon with NN2211, a GLP-1 derivative, in subjects with type 2-diabetes;M Nauck;Diabetes,2003

5. Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme;K Niswender;Diabetes Obes Metab,2013

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Protective Properties of GLP-1 Receptor Agonists: More than Just Diabetic and Weight Loss Drugs;Journal of Clinical Medicine;2024-08-09

2. Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance;International Journal of Molecular Sciences;2024-08-08

3. The benefits of oral glucose-lowering agents: GLP-1 receptor agonists, DPP-4 and SGLT-2 inhibitors on myocardial ischaemia/reperfusion injury;European Journal of Pharmacology;2024-08

4. Liraglutide effects on epicardial adipose tissue micro-RNAs and intra-operative glucose control;Nutrition, Metabolism and Cardiovascular Diseases;2024-08

5. Anti-inflammatory effect of semaglutide: updated systematic review and meta-analysis;Frontiers in Cardiovascular Medicine;2024-07-05